Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novavax NVAX -- Ignore unavailable to you. Want to Upgrade?

To: MJ who wrote (11)	5/19/2009 11:09:58 PM
From: Rock_nj	Read Replies (1) \| Respond to of 166

U.S. Taking Wait-and-See Approach to Vaccine While many industrialized nations including Britain, Canada, Denmark, France, and Switzerland have already placed orders for the vaccine once it is available, the United States has not. U.S. Health and Human Services Secretary Kathleen Sebelius said Tuesday that the U.S. feels a responsibility to allow poorer nations to receive antiviral drugs and any new vaccine. The U.S. is still not sure how many vaccinations it would order, who would be first in line to receive the vaccinations, and other details, Sebelius said. Since the outbreak of H1N1 influenza began in April 2009, 81 people have died from the disease, including 72 in Mexico, seven in the U.S., one in Canada and one in Costa Rica, officials said. The United States has the most confirmed cases of the virus followed by Mexico and Canada. attorneyatlaw.com Where is the U.S. Going to get the swine flu vaccine that it needs? Novavax will be there to fill the void. This could be the stock that people look back at when the year ends and wonder why they didn't jump on board earlier in the year.